Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimizing Response in Psychosis Study

NCT00314327 is registered in ClinicalTrials.gov with Northwell Health as lead sponsor.

NCT NCT00314327
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00314327 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimizing Response in Psychosis Study
Lead sponsor
Northwell Health
Phase
Phase 4
Overall status
Terminated
Start date
April 30, 2006
Completion date
November 30, 2013
Enrollment
1 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

psychotic disorder not otherwise specified, schizoaffective disorder, schizophrenia, schizophreniform disorder